LAURA MCDERMOTT: Open Payments
NPI 1134536691 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$865 in 28 payments from 9 companies in 2025. Trend: 2023 $927 · 2024 $1,485 · 2025 $865
Food & beverage: $865
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 7 | $259 |
| AstraZeneca Pharmaceuticals LP | 5 | $183 |
| Ancora Heart, Inc. | 2 | $132 |
| Novartis Pharmaceuticals Corporation | 6 | $117 |
| E.R. Squibb & Sons, L.L.C. | 4 | $97 |
| ABIOMED | 1 | $24 |
| Baxter Healthcare | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| PFIZER INC. | 1 | $16 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, FARXIGA, AccuCinch, LEQVIO, ELIQUIS, CAMZYOS, PERCLOT, VERQUVO.
Industry payments across NM — which companies pay providers there.
